BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.8% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5301
Invesco Bloomberg Pricing Power ETF
POWA
$168M
| $4.44K | ﹤0.01% |
+50
| New | +$4.39K |
2026 Q2
0 quarters
|
|
5302
enVVeno Medical
NVNO
$4.68M
| $4.43K | ﹤0.01% |
414
-1,426
| -78% | -$15.4K |
2021 Q2
20 quarters
|
|
5303
Senti Biosciences Holdings
SNTI
$6.15M
| $4.4K | ﹤0.01% |
4,004
-21,070
| -84% | -$20.6K |
2022 Q3
15 quarters
|
|
5304
Biofrontera
BFRI
$12.3M
| $4.37K | ﹤0.01% |
4,622
| – | – |
2021 Q4
18 quarters
|
|
5305
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
$1.37B
| $4.21K | ﹤0.01% |
+200
| New | +$3.82K |
2026 Q2
0 quarters
|
|
5306
Envoy Medical
COCH
$55.4M
| $4.2K | ﹤0.01% |
531
-4,220
| -89% | -$28.7K |
2024 Q1
9 quarters
|
|
5307
GT Biopharma
GTBP
$7.98M
| $4.07K | ﹤0.01% |
332
-4
| -1% | -$41 |
2021 Q2
20 quarters
|
|
5308
iShares iBonds Dec 2030 Term Muni Bond ETF
IBMS
$388M
| $3.91K | ﹤0.01% |
151
| – | – |
2024 Q2
8 quarters
|
|
5309
iShares HYG Premium Income+ ETF
HYGW
$109M
| $3.84K | ﹤0.01% |
132
-548
| -81% | -$15.9K |
2024 Q4
6 quarters
|
|
5310
iShares iBonds Dec 2029 Term Muni Bond ETF
IBMR
$527M
| $3.83K | ﹤0.01% |
151
| – | – |
2023 Q2
12 quarters
|
|
5311
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$2.81B
| $3.83K | ﹤0.01% |
158
-591,544
| -100% | -$14.3M |
2021 Q3
19 quarters
|
|
5312
Evolution Metals & Technologies Corp
EMAT
$1.23B
| $3.8K | ﹤0.01% |
575
-9,252
| -94% | -$73.4K |
2026 Q1
1 quarter
|
|
5313
Fidelity MSCI Real Estate Index ETF
FREL
$1.43B
| $3.78K | ﹤0.01% |
+129
| New | +$3.74K |
2026 Q2
0 quarters
|
|
5314
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
$503M
| $3.77K | ﹤0.01% |
147
| – | – |
2021 Q3
19 quarters
|
|
5315
Cadeler plc
CDLR
$2.6B
| $3.75K | ﹤0.01% |
684
| – | – |
2024 Q4
6 quarters
|
|
5316
Putnam Focused Large Cap Value ETF
PVAL
$15.2B
| $3.67K | ﹤0.01% |
+72
| New | +$3.58K |
2026 Q2
0 quarters
|
|
5317
SeaStar Medical
ICU
$10M
| $3.35K | ﹤0.01% |
913
| – | – |
2024 Q1
9 quarters
|
|
5318
Nouveau Monde Graphite
NMG
$275M
| $3.21K | ﹤0.01% |
2,138
| – | – |
2021 Q3
19 quarters
|
|
5319
Solitario Resources
XPL
$46.5M
| $3.11K | ﹤0.01% |
4,130
+2,803
| +211% | +$2.34K |
2024 Q2
8 quarters
|
|
5320
Skyline Builders Group
KAZR
$23.1M
| $3.08K | ﹤0.01% |
998
| – | – |
2025 Q1
5 quarters
|
|
5321
Generation Income Properties
GIPR
$774K
| $2.95K | ﹤0.01% |
1,765
-273
| -13% | -$705 |
2022 Q4
14 quarters
|
|
5322
John Wiley & Sons Class B
WLYB
| $2.9K | ﹤0.01% |
62
| – | – |
2019 Q4
26 quarters
|
|
|
RITR
5323
DELISTED
Reitar Logtech Holdings
RITR
| $2.87K | ﹤0.01% |
6,072
| – | – |
2025 Q4
2 quarters
|
|
5324
Global Indemnity Group
GBLI
$318M
| $2.85K | ﹤0.01% |
114
| – | – |
2021 Q1
21 quarters
|
|
5325
Oncolytics Biotech
ONCY
$57.6M
| $2.85K | ﹤0.01% |
3,000
| – | – |
2024 Q4
6 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 244 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 244 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.